Immunotherapy After Chemotherapy Could Slow Progression of Urothelial Cancer

A recent study found that switch maintenance therapy after first-line platinum-based chemotherapy led to higher objective response rates and longer progression-free survival for patients of urothelial cancer.

Source: CancerNetwork - April 19, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news